Literature DB >> 18261882

Classification accuracy of the Portland digit recognition test in persons claiming exposure to environmental and industrial toxins.

Kevin W Greve1, Kevin J Bianchini, Matthew T Heinly, Jeffrey M Love, Douglas A Swift, Megan Ciota.   

Abstract

The classification accuracy of the Portland digit recognition test (PDRT) in detecting cognitive malingering was studied in patients claiming cognitive deficits due to exposure to environmental or industrial toxins. Twenty-nine patients alleging toxic exposure and who met Slick et al. [Slick, D. J., Sherman, E. M. S., & Iverson, G. L. (1999). Diagnostic criteria for malingering neurocognitive dysfunction: Proposed standards for clinical practice and research. The Clinical Neuropsychologist, 13, 545-561] criteria for malingered neurocognitive dysfunction were compared to 14 toxic exposure patients negative for evidence of malingering. The published cutoffs were associated with a false positive error rate of 0% and sensitivity of more than 50%. When criterion for a PDRT failure was a positive PDRT finding on more than one section, the FP rate remained 0% while sensitivity improved to about 70%. The results indicate that a failed PDRT is an indication of malingering and not the neurological effect of a toxic substance or some other clinical phenomenon. The PDRT can be used with confidence as an indicator of negative response bias in cases of alleged exposure to neurotoxic substances.

Entities:  

Mesh:

Year:  2008        PMID: 18261882     DOI: 10.1016/j.acn.2007.12.001

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  1 in total

1.  A novel methodology for the objective ascertainment of psychic and existential damage.

Authors:  Santo Davide Ferrara; Viviana Ananian; Eric Baccino; Rafael Boscolo-Berto; Ranieri Domenici; Claudio Hernàndez-Cueto; George Mendelson; Gian Aristide Norelli; Mohammed Ranavaya; Claudio Terranova; Duarte Nuno Vieira; Guido Viel; Enrique Villanueva; Riccardo Zoia; Giuseppe Sartori
Journal:  Int J Legal Med       Date:  2016-05-04       Impact factor: 2.686

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.